High serum concentrations of phosphate and linked parameters of phosphorus homeostasis, such as parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF-23), are associated with increased morbidity and mortality in patients with chronic kidney disease [13,14]. The gene discussed is PTH; the disease is chronic kidney disease.